Trial NCT04388514
Publication Sozio E, Int Immunopharmacol, 2021
Primary outcome on the report: Negative SIMEU delta classes (negative values implying clinical improvement) assessed on the day following day 3 and 10; admission to Intensive Care Unit; death.

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.